Israeli R&D Team Claim To Be Near COVID-19 Vaccine
MIGAL Researchers Had Already Developed An Avian Coronavirus Vaccine
Executive Summary
An Israeli research team has discovered a potential COVID-19 vaccine candidate as a by-product of an avian vaccine they were developing and one of the team’s leaders told Scrip they hope to start producing and testing it by May.
You may also be interested in...
Ipsen Buys Into BAX Inhibitor, Targeting Certain Cancers
Ipsen has inked a worldwide collaboration pact with BAKX Therapeutics to research, develop, manufacture and commercialize the biotech’s asset BKX-001 as a potential treatment for leukemia, lymphoma and solid tumors.
Roche R&D Spending Surge Reflects In-House Innovation, M&A Prices
A surprise surge in Roche's R&D spending this year reflects high quality in-house innovation opportunities as well as high prices for external M&A targets, management said.
Roche Deals With Huge Gantenerumab Curiosity At H1 Update
Roche unveiled a strong Q2 performance driven by new medicines and continued strong growth from its diagnostics division but analysts were most keen for clues on plans for gantenerumab, now in Phase III studies for Alzheimer’s disease.